Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Immunology
|
August 1, 1987
Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion
Y Yoshiyama, W R Brown
No to Shinkei = Brain and Nerve
|
January 1, 1997
[Expression of interferon-alpha mRNA in human brain tissues]
N Kawaguchi, T Yamada, Y Yoshiyama
Neuroreport
|
August 28, 2001
Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease
Y Yoshiyama, K Arai, T Hattori
Acta Neuropathologica
|
February 15, 2000
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
Y Yoshiyama, M Asahina, T Hattori
Journal of the Neurological Sciences
|
September 29, 1999
The dropped head sign in parkinsonism
Y Yoshiyama, J Takama, T Hattori
Clinical Neuropathology
|
May 1, 2001
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain
M Asahina, Y Yoshiyama, T Hattori
Brain Research
|
February 28, 1997
Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues
T Yamada, Y Yoshiyama, N Kawaguchi
Journal of Clinical Pharmacology
|
November 1, 1989
Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration
Y Yoshiyama, S Nakano, N Ogawa
The Japanese Journal of Antibiotics
|
March 10, 2001
Nephrotoxicity of teicoplanin in rats
Y Yoshiyama, T Yazaki, M Kanke, et al.
Journal of Pharmacobio-Dynamics
|
August 1, 1992
Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration
Y Yoshiyama, S Nakano, S Ohdo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Immunology
|
August 1, 1987
Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion
Y Yoshiyama, W R Brown
No to Shinkei = Brain and Nerve
|
January 1, 1997
[Expression of interferon-alpha mRNA in human brain tissues]
N Kawaguchi, T Yamada, Y Yoshiyama
Neuroreport
|
August 28, 2001
Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease
Y Yoshiyama, K Arai, T Hattori
Acta Neuropathologica
|
February 15, 2000
Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain
Y Yoshiyama, M Asahina, T Hattori
Journal of the Neurological Sciences
|
September 29, 1999
The dropped head sign in parkinsonism
Y Yoshiyama, J Takama, T Hattori
Clinical Neuropathology
|
May 1, 2001
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain
M Asahina, Y Yoshiyama, T Hattori
Brain Research
|
February 28, 1997
Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues
T Yamada, Y Yoshiyama, N Kawaguchi
Journal of Clinical Pharmacology
|
November 1, 1989
Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration
Y Yoshiyama, S Nakano, N Ogawa
The Japanese Journal of Antibiotics
|
March 10, 2001
Nephrotoxicity of teicoplanin in rats
Y Yoshiyama, T Yazaki, M Kanke, et al.
Journal of Pharmacobio-Dynamics
|
August 1, 1992
Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration
Y Yoshiyama, S Nakano, S Ohdo, et al.
Page
of 6